This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ASM journals Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plaisance, K I Articles by Standiford, H C Search for Related Content PubMed PubMed Citation Articles by Plaisance, K I Articles by Standiford, H C

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1989 May; 33(5): 618-620

Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate.

K I Plaisance, G L Drusano, A Forrest, R J Townsend and H C Standiford

School of Pharmacy, University of Maryland, Baltimore 21201.

ABSTRACT

Interpretation of the majority of data on the disposition of clindamycin is confounded by the presence of active metabolites, which may interfere with commonly employed bioassays. We undertook a multiple-dose study of the disposition of clindamycin phosphate and clindamycin, given either as 600 mg intravenously every 6 h or 1,200 mg intravenously every 12 h for five and three doses, respectively, in six healthy volunteers. Concentrations in serum and urine were analyzed by a specific gas chromatography assay. Maximum and minimum clindamycin concentrations in serum and the area under the serum concentration-time curve following the first dose were similar to those observed at the steady state. The mean and standard deviation of the maximum, 1-h postdose, and minimum concentrations in serum at steady state for the 600-mg dose given every 6 h were 16.8 +/- 6.0, 7.6 +/- 0.7, and 2.3 +/- 0.9 microgram/ml, whereas for the 1,200-mg dose given every 12 h they were 17.2 +/- 3.5, 9.8 +/- 1.5, and 0.6 +/- 0.3 microgram/ml, respectively. For the 12-h regimen, clindamycin concentrations in serum remained above 2 micrograms/ml for 7 h. The decay of clindamycin phosphate levels in serum was rapid, with virtually 100% of the phosphate eliminated within the first 1.5 h following the dose. Approximately 0.35 and 4.5% of the administered dose were recovered in the urine as clindamycin phosphate and clindamycin, respectively. Further pharmacokinetic evaluation of the 12-hourly dosage regimen should be done before clinical evaluation in infected patients is undertaken.

---

Antimicrob Agents Chemother. 1989 May; 33(5): 618-620

This article has been cited by other articles:

• Finegold, S. M., Bolanos, M., Sumannen, P. H., Molitoris, D. R. (2009). In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates. Antimicrob. Agents Chemother. 53: 3996-4001 [Abstract] [Full Text]